These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20412532)

  • 1. The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange.
    Bentley MJ; Lehman CM; Blaylock RC; Wilson AR; Rodgers GM
    Transfusion; 2010 Aug; 50(8):1654-64. PubMed ID: 20412532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort.
    Bentley MJ; Wilson AR; Rodgers GM
    Vox Sang; 2013 Nov; 105(4):313-8. PubMed ID: 23662653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
    Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
    Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
    Yagi H; Matsumoto M; Fujimura Y
    Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura.
    Connell NT; Cheves T; Sweeney JD
    Transfusion; 2016 Feb; 56(2):354-9. PubMed ID: 26456149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura--the role of ADAMTS13 assay in clinical practice.
    Duraković N; Radonić R; Gasparović V
    Coll Antropol; 2010 Sep; 34(3):1087-91. PubMed ID: 20977108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura.
    Barrows BD; Teruya J
    Arch Pathol Lab Med; 2014 Apr; 138(4):546-9. PubMed ID: 24678685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura.
    Wu N; Liu J; Yang S; Kellett ET; Cataland SR; Li H; Wu HM
    Transfusion; 2015 Jan; 55(1):18-24. PubMed ID: 24953079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study on five cases of thrombotic thrombocytopenic purpura complicating pregnancy.
    He Y; Chen Y; Zhao Y; Zhang Y; Yang W
    Aust N Z J Obstet Gynaecol; 2010 Dec; 50(6):519-22. PubMed ID: 21133861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of ADAMTS13 activity and inhibitor in the postmortem diagnosis of thrombotic thrombocytopenic purpura.
    Dwyre DM; Dursteler B; Nashelsky M; Friedman KD; Raife TJ
    J Clin Apher; 2009; 24(3):106-10. PubMed ID: 19253359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on the significance of plasma thrombospondin1 in thrombotic thrombocytopenic purpura and the relationship between thrombospondin1 and von Willebrand factor cleaving protease (ADAMTS13)].
    Liu F; Lu GY; Dong NZ; Bai X; Su J; Ruan CG
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3190-3. PubMed ID: 16405838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura.
    Hong H; Xiao W; Stempak LM; Sandhaus LM; Maitta RW
    Transfusion; 2015 Apr; 55(4):756-65. PubMed ID: 25370931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma.
    Isonishi A; Bennett CL; Plaimauer B; Scheiflinger F; Matsumoto M; Fujimura Y
    Transfusion; 2015 Oct; 55(10):2321-30. PubMed ID: 26058519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.
    Nikolaou M; Karakantza M; Adonakis G; Theodorou G; Zoumbos N; Decavalas G
    Med Pregl; 2012; 65(9-10):436-9. PubMed ID: 23214340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
    Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
    Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.
    O'Brien KL; Price TH; Howell C; Delaney M
    J Clin Apher; 2013 Dec; 28(6):416-21. PubMed ID: 23857424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial ADAMTS13 measurements during initial plasma exchange therapy guide decisions for management of unresponsive thrombotic thrombocytopenic purpura.
    van der Veen BS; Besseling R; Hoogendoorn M
    Transfusion; 2015 Oct; 55(10):2511-5. PubMed ID: 26308736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.